• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any of the side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

1. What ARICEPT EVESS is and what it is used for
2. What you need to know before you take ARICEPT EVESS
3. How to take ARICEPT EVESS
4. Possible side effects
5. How to store ARICEPT EVESS
6. Contents of the pack and other information

• if you are allergic to donepezil hydrochloride, or to piperidine derivatives, or any of the other ingredients of this medicine (listed in section 6).

Talk to your doctor or pharmacist before taking ARICEPT EVESS if you have or have had:

• stomach or duodenal ulcers
• seizures (fits) or convulsions
• a heart condition (such as irregular or very slow heart beat, heart failure, myocardial infarction)
• a heart condition called ‘prolonged QT interval’ or a history of certain abnormal heart rhythms called Torsade de Pointes or if anyone in your family has ‘prolonged QT interval’
• low levels of magnesium or potassium in your blood
• asthma or other long term lung disease
• liver problems or hepatitis
• difficulty passing urine or mild kidney disease

Also tell your doctor if you are pregnant or think you might be pregnant.

ARICEPT EVESS is not recommended for use in children and adolescents (younger than 18 years of age).

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that your doctor has not prescribed for you but which you have bought yourself from a chemist/pharmacist. It also applies to medicines you may take some time in the future if you continue to take ARICEPT EVESS. This is because these medicines may weaken or strengthen the effects of ARICEPT EVESS.

In particular it is important to tell your doctor if you are taking any of the following types of medicines:

• medicines for heart rhythm problems e.g. amiodarone, sotalol
• medicines for depression e.g. citalopram, escitalopram, amitriptyline, fluoxetine
• medicines for psychosis e.g. pimozide, sertindole, ziprasidone
• medicines for bacterial infections e.g. clarithromycin, erythromycin, levofloxacin, moxifloxacin, rifampicin
• anti-fungal medicines e.g. ketoconazole
• other Alzheimer’s disease medicines, e.g. galantamine
• pain killers or treatment for arthritis e.g. aspirin, non-steroidal anti-inflammatory (NSAID) drugs such as ibuprofen, or diclofenac sodium
• anticholinergic medicines, e.g. tolterodine
• anticonvulsants e.g. phenytoin, carbamazepine
• medication for a heart condition e.g. quinidine, beta-blockers (propranolol and atenolol)
• muscle relaxants e.g. diazepam, succinylcholine
• general anaesthetic
• medicines obtained without a prescription e.g. herbal remedies

If you are going to have an operation that requires you to have a general anaesthetic, you should tell your doctor and the anaesthetist that you are taking ARICEPT EVESS. This is because your medicine may affect the amount of anaesthetic needed.

ARICEPT EVESS can be used in patients with kidney disease or mild to moderate liver disease. Tell your doctor first if you have kidney or liver disease. Patients with severe liver disease should not take ARICEPT EVESS.

Tell your doctor or pharmacist the name of your caregiver. Your caregiver will help you to take your medicine as it is prescribed.

Food will not influence the effect of ARICEPT EVESS.

ARICEPT EVESS should not be taken with alcohol because alcohol may change its effect.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking any medicine.

ARICEPT EVESS should not be used while breast-feeding.

Alzheimer’s disease may impair your ability to drive or operate machinery and you must not perform these activities unless your doctor tells you that it is safe to do so.

Also, your medicine can cause tiredness, dizziness and muscle cramp. If you experience any of these effects you must not drive or operate machinery.

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Initially, the recommended dose is 5 mg (one white tablet) every night before you go to bed. After one month, your doctor may tell you to take 10 mg (one yellow tablet) every night before you go to bed.

If you experience abnormal dreams, nightmares or difficulty in sleeping (see section 4) your doctor may advise you to take ARICEPT EVESS in the morning.

The tablet strength you will take may change depending on the length of time you have been taking the medicine and on what your doctor recommends. The maximum recommended dose is 10 mg each night.

Always follow your doctor or pharmacist’s advice about how and when to take your medicine.

Do not alter the dose yourself without your doctor’s advice.

The tablet should be placed on your tongue and allowed to disintegrate before swallowing, with or without water, according to your preference.

ARICEPT EVESS is not recommended for use in children and adolescents (younger than 18 years of age).

Contact your doctor or the nearest hospital emergency department immediately if you take more of the medicine than you should. Take this leaflet and any remaining tablets with you.

Overdose symptoms may include nausea (feeling sick) and vomiting (being sick), drooling, sweating, slow heart rate, low blood pressure (light-headedness or dizziness when standing), breathing problems, losing consciousness and seizures (fits) or convulsions.

If you forget to take your medicine, take the next dose at the usual time. Do not take a double dose to make up for a forgotten tablet.

If you forget to take your medicine for more than one week, call your doctor before taking any more medicine.

Do not stop taking the tablets unless told to do so by your doctor. If you stop taking ARICEPT EVESS, the benefits of your treatment will gradually fade away.

Your doctor or pharmacist will advise you on how long you should continue to take your tablets. You will need to see your doctor from time to time to review your treatment and assess your symptoms.

You must tell your doctor immediately if you notice these serious side effects mentioned. You may need urgent medical treatment.

• liver damage e.g. hepatitis. The symptoms of hepatitis are nausea (feeling sick) or vomiting (being sick), loss of appetite, feeling generally unwell, fever, itching, yellowing of the skin and eyes, and dark coloured urine (may affect up to 1 in 1,000 people)
• stomach or duodenal ulcers. The symptoms of ulcers are stomach pain and discomfort (indigestion) felt between the navel and the breast bone (may affect up to 1 in 100 people)
• bleeding in the stomach or intestines. This may cause you to pass black tar like stools or visible blood from the rectum (may affect up to 1 in 100 people)
• seizures (fits) or convulsions (may affect up to 1 in 100 people)
• fever with muscle stiffness, sweating or a lowered level of consciousness (a disorder called “Neuroleptic Malignant Syndrome”) (may affect up to 1 in 10,000 people)
• muscle weakness, tenderness or pain and particularly, if at the same time, you feel unwell, have a high temperature or have dark urine. They may be caused by an abnormal muscle breakdown which can be life threatening and lead to kidney problems (a condition called rhabdomyolysis) (may affect up to 1 in 10,000 people)
• fast, irregular heart beat and fainting, which could be symptoms of a life-threatening condition known as Torsade de Pointes (frequency cannot be estimated from the available data)

Very common side effects (may affect more than 1 in 10 people):

• diarrhoea
• headache

Common side effects (may affect up to 1 in 10 people):

• muscle cramp
• tiredness
• difficulty in sleeping (insomnia)
• the common cold
• hallucinations (seeing or hearing things that are not really there)
• unusual dreams including nightmares
• agitation
• aggressive behaviour
• fainting
• dizziness
• stomach feeling uncomfortable
• rash
• passing urine uncontrollably
• pain
• accidents (patients may be more prone to falls and accidental injury)

Uncommon side effects (may affect up to 1 in 100 people):

• slow heart beat
• salivary hypersecretion

Rare side effects (may affect up to 1 in 1000 people):

• stiffness, shaking or uncontrollable movement especially of the face and tongue but also of the limbs

Not known (frequency cannot be estimated from the available data)

• Changes in the heart activity which can be seen on an electro-cardiogram (ECG) called ‘prolonged QT interval’
• libido increased, hypersexuality
• Pisa syndrome (a condition involving involuntary muscle contraction with abnormal bending of the body and head to one side)

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

• The active substance is donepezil hydrochloride. Two different strengths of tablets are available. Each 5 mg orodispersible tablet contains 5 mg of donepezil hydrochloride and each 10 mg orodispersible tablet contains 10 mg of donepezil hydrochloride.
• The other ingredients are mannitol, colloidal anhydrous silica, k-carrageenan, and polyvinyl alcohol.
• Additionally, the 10 mg orodispersible tablet contains synthetic yellow iron oxide (E172).

• ARICEPT EVESS 5 mg orodispersible tablets are white, round tablets marked ‘ARICEPT’ on one side and ‘5’ on the other side.
• ARICEPT EVESS 10 mg orodispersible tablets are yellow, round tablets marked ‘ARICEPT’ on one side and ‘10’ on the other side.

ARICEPT EVESS is available in packs of:

7, 14, 28, 30, 50, 56, 60, 98 and 120 orodispersible tablets in blister packs.

Not all pack sizes may be marketed.

Marketing Authorisation Holder:

Manufacturer: